Skip to Main Content

Paper Details

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
Circulation
51
2022
Author NameAffiliation
Mikhail KosiborodSaint Luke's Mid America Heart Institute
Mikhail KosiborodUniversity of Missouri-Kansas City (M.N.K.
Mikhail KosiborodThe George Institute for Global Health, University of New South Wales
Christiane E AngermannUniversity and University Hospital of Wurzburg
Sean P CollinsVanderbilt University Medical Center
Sean P CollinsGeriatric Research and Education Clinical Care, Tennessee Valley Healthcare Facility VA Medical Center
John R TeerlinkSan Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco (J.R.T.).
  • 1 - 7

Datasets

Release 1.2